valproic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

valproic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bodard, S; Castelnau, P; Chalon, S; Gressens, P; Lagrue, E; Saliba, E1
Castro, AA; Ghisoni, K; Latini, A; Prediger, RD; Quevedo, J; Tasca, CI1
Birangal, SR; Bojja, SL; Kumar, G; Meka, ST; Rao, CM1

Other Studies

3 other study(ies) available for valproic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice.
    Pediatric research, 2007, Volume: 62, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Apoptosis; Corpus Striatum; Dopamine; Dopamine Agents; Energy Metabolism; Fructose; Lamotrigine; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Topiramate; Triazines; Valproic Acid

2007
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
    Behavioural brain research, 2012, Apr-01, Volume: 229, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Age Factors; Animals; Animals, Newborn; Avoidance Learning; Chromatography, High Pressure Liquid; Discrimination, Psychological; Disease Models, Animal; Dopamine; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Lithium; Male; Memory Disorders; Memory, Short-Term; Neuroprotective Agents; Neurotoxins; Olfaction Disorders; Parkinsonian Disorders; Rats; Rats, Wistar; Recognition, Psychology; Serotonin; Statistics, Nonparametric; Swimming; Valproic Acid

2012
Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats.
    European journal of pharmacology, 2023, Nov-15, Volume: 959

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Histone Deacetylase Inhibitors; Mice; Mice, Inbred C57BL; Neuroprotection; Neuroprotective Agents; Parkinson Disease; Rats; Valproic Acid

2023